Literature DB >> 9536285

p53 mutations in multiple myeloma.

S Paydaś, B Sahin, E Seyrek, S Zorludemir.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9536285      PMCID： PMC379669          DOI： 10.1136/mp.50.6.329-a

Source DB:  PubMed          Journal:  Mol Pathol        ISSN： 1366-8714


× No keyword cloud information.
  7 in total

1.  Rare occurrence of P53 gene mutations in multiple myeloma.

Authors:  C Preudhomme; T Facon; M Zandecki; M Vanrumbeke; J L Laï; E Nataf; M H Loucheux-Lefebvre; J P Kerckaert; P Fenaux
Journal:  Br J Haematol       Date:  1992-07       Impact factor: 6.998

2.  p53 gene mutations in multiple myeloma.

Authors:  R G Owen; S A Davis; J Randerson; A C Rawstron; F Davies; J A Child; A S Jack; G J Morgan
Journal:  Mol Pathol       Date:  1997-02

Review 3.  Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.

Authors:  M Prokocimer; V Rotter
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

4.  Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.

Authors:  P Corradini; G Inghirami; M Astolfi; M Ladetto; C Voena; P Ballerini; W Gu; K Nilsson; D M Knowles; M Boccadoro
Journal:  Leukemia       Date:  1994-05       Impact factor: 11.528

5.  Mutations of the p53 gene in human myeloma cell lines.

Authors:  G R Mazars; M Portier; X G Zhang; M Jourdan; R Bataille; C Theillet; B Klein
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

6.  p53 and RAS gene mutations in multiple myeloma.

Authors:  M Portier; J P Molès; G R Mazars; P Jeanteur; R Bataille; B Klein; C Theillet
Journal:  Oncogene       Date:  1992-12       Impact factor: 9.867

7.  p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy.

Authors:  A Neri; L Baldini; D Trecca; L Cro; E Polli; A T Maiolo
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113
  7 in total
  1 in total

1.  An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma.

Authors:  Wei Xiong; Xiaosong Wu; Sarah Starnes; Sarah K Johnson; Jeff Haessler; Siqing Wang; Lijuan Chen; Bart Barlogie; John D Shaughnessy; Fenghuang Zhan
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.